These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38139015)

  • 1. Comparison of Nanopore and Synthesis-Based Next-Generation Sequencing Platforms for SARS-CoV-2 Variant Monitoring in Wastewater.
    Garcia-Pedemonte D; Carcereny A; Gregori J; Quer J; Garcia-Cehic D; Guerrero L; Ceretó-Massagué A; Abid I; Bosch A; Costafreda MI; Pintó RM; Guix S
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of variant calling algorithms for wastewater-based epidemiology using mixed populations of SARS-CoV-2 variants in synthetic and wastewater samples.
    Bassano I; Ramachandran VK; Khalifa MS; Lilley CJ; Brown MR; van Aerle R; Denise H; Rowe W; George A; Cairns E; Wierzbicki C; Pickwell ND; Carlile M; Holmes N; Payne A; Loose M; Burke TA; Paterson S; Wade MJ; Grimsley JMS
    Microb Genom; 2023 Apr; 9(4):. PubMed ID: 37074153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of SARS-CoV-2 sequencing using the ONT GridION and the Illumina MiSeq.
    Tshiabuila D; Giandhari J; Pillay S; Ramphal U; Ramphal Y; Maharaj A; Anyaneji UJ; Naidoo Y; Tegally H; San EJ; Wilkinson E; Lessells RJ; de Oliveira T
    BMC Genomics; 2022 Apr; 23(1):319. PubMed ID: 35459088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of methods for SARS-CoV-2 variant detection and abundance estimation within mixed population samples.
    Kayikcioglu T; Amirzadegan J; Rand H; Tesfaldet B; Timme RE; Pettengill JB
    PeerJ; 2023; 11():e14596. PubMed ID: 36721781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECNano: A cost-effective workflow for target enrichment sequencing and accurate variant calling on 4800 clinically significant genes using a single MinION flowcell.
    Leung AW; Leung HC; Wong CL; Zheng ZX; Lui WW; Luk HM; Lo IF; Luo R; Lam TW
    BMC Med Genomics; 2022 Mar; 15(1):43. PubMed ID: 35246132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel High-Throughput Nanopore-Sequencing-Based Strategy for Rapid and Automated S-Protein Typing of SARS-CoV-2 Variants.
    Wagner GE; Totaro MG; Volland A; Lipp M; Saiger S; Lichtenegger S; Forstner P; von Laer D; Oberdorfer G; Steinmetz I
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescuing low frequency variants within intra-host viral populations directly from Oxford Nanopore sequencing data.
    Liu Y; Kearney J; Mahmoud M; Kille B; Sedlazeck FJ; Treangen TJ
    Nat Commun; 2022 Mar; 13(1):1321. PubMed ID: 35288552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Oxford Nanopore Technologies and Illumina MiSeq sequencing with mock communities and agricultural soil.
    Stevens BM; Creed TB; Reardon CL; Manter DK
    Sci Rep; 2023 Jun; 13(1):9323. PubMed ID: 37291169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Whole-Genome Sequencing Using Oxford Nanopore Technology for Variant Monitoring in Wastewaters.
    Barbé L; Schaeffer J; Besnard A; Jousse S; Wurtzer S; Moulin L; ; Le Guyader FS; Desdouits M
    Front Microbiol; 2022; 13():889811. PubMed ID: 35756003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted-Sequencing Workflows for Comprehensive Drug Resistance Profiling of Mycobacterium tuberculosis Cultures Using Two Commercial Sequencing Platforms: Comparison of Analytical and Diagnostic Performance, Turnaround Time, and Cost.
    Tafess K; Ng TTL; Lao HY; Leung KSS; Tam KKG; Rajwani R; Tam STY; Ho LPK; Chu CMK; Gonzalez D; Sayada C; Ma OCK; Nega BH; Ameni G; Yam WC; Siu GKH
    Clin Chem; 2020 Jun; 66(6):809-820. PubMed ID: 32402055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplicon-Based, Next-Generation Sequencing Approaches to Characterize Single Nucleotide Polymorphisms of
    Taylor MK; Williams EP; Wongsurawat T; Jenjaroenpun P; Nookaew I; Jonsson CB
    Front Cell Infect Microbiol; 2020; 10():565591. PubMed ID: 33163416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary study on the potential of Nanopore MinION and Illumina MiSeq 16S rRNA gene sequencing to characterize building-dust microbiomes.
    Nygaard AB; Tunsjø HS; Meisal R; Charnock C
    Sci Rep; 2020 Feb; 10(1):3209. PubMed ID: 32081924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of strategies for the assembly of diverse bacterial genomes using MinION long-read sequencing.
    Goldstein S; Beka L; Graf J; Klassen JL
    BMC Genomics; 2019 Jan; 20(1):23. PubMed ID: 30626323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequencing of SARS-CoV-2 genome using different nanopore chemistries.
    González-Recio O; Gutiérrez-Rivas M; Peiró-Pastor R; Aguilera-Sepúlveda P; Cano-Gómez C; Jiménez-Clavero MÁ; Fernández-Pinero J
    Appl Microbiol Biotechnol; 2021 Apr; 105(8):3225-3234. PubMed ID: 33792750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of MinION nanopore data for resequencing analyses.
    Magi A; Giusti B; Tattini L
    Brief Bioinform; 2017 Nov; 18(6):940-953. PubMed ID: 27559152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative sequencing data analysis of Ion Torrent and MinION sequencing platforms using a clinical diagnostic haematology panel.
    Singh A; Bhatia P
    Int J Lab Hematol; 2020 Dec; 42(6):833-841. PubMed ID: 32654382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a Multiplex Real-Time PCR Technique with Oxford Nanopore Technologies Next-Generation Sequencing for Identification of SARS-CoV-2 Variants of Concern.
    Ahmadi Z; Maleki A; Eybpoosh S; Fereydouni Z; Tavakoli M; Kashanian S; Farhan Asadi L; Nemati AH; Salehi-Vaziri M
    Intervirology; 2023; 66(1):136-141. PubMed ID: 37812919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and economical drug resistance profiling with Nanopore MinION for clinical specimens with low bacillary burden of Mycobacterium tuberculosis.
    Chan WS; Au CH; Chung Y; Leung HCM; Ho DN; Wong EYL; Lam TW; Chan TL; Ma ESK; Tang BSF
    BMC Res Notes; 2020 Sep; 13(1):444. PubMed ID: 32948225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Targeted Next-Generation Sequencing Assay on a Portable Sequencing Platform for Culture-Free Detection of Drug-Resistant Tuberculosis from Clinical Samples.
    Cabibbe AM; Spitaleri A; Battaglia S; Colman RE; Suresh A; Uplekar S; Rodwell TC; Cirillo DM
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32727827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The newest Oxford Nanopore R10.4.1 full-length 16S rRNA sequencing enables the accurate resolution of species-level microbial community profiling.
    Zhang T; Li H; Ma S; Cao J; Liao H; Huang Q; Chen W
    Appl Environ Microbiol; 2023 Oct; 89(10):e0060523. PubMed ID: 37800969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.